Prosperity Wealth Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
Other funds holding KNSA
BBA
Prosperity Wealth Management's KNSA Position: Q3 2026 in Review
Prosperity Wealth Management opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q3 2026: 10,000 shares worth $746K. The stake represents 0.15% of the portfolio and ranks #123 among its holdings. This is a return to the name: Prosperity Wealth Management previously reported a position in KNSA as recently as Q3 2025.
Prosperity Wealth Management first reported a position in KNSA in Q3 2025 and has held it in 2 quarters since. 305 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.
- Prosperity Wealth Management held 10,000 shares of Kiniksa Pharmaceuticals worth $746K as of Q3 2026.
- Kiniksa Pharmaceuticals was a new Prosperity Wealth Management position in Q3 2026.
- Kiniksa Pharmaceuticals made up 0.15% of Prosperity Wealth Management's portfolio in Q3 2026, its #123 holding.
- Prosperity Wealth Management first reported a position in Kiniksa Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
- 305 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.
Based on Prosperity Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.